Skip to main content
Watch Insiders

Corporate insider profile

Richard A. Heyman Insider Trades

Latest reported as Director of Oric Pharmaceuticals, Inc. (ORIC).

Purchase filings
0
Reported companies
1
Net open-market value
-$247,586.47
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

ORICLatest reported

Oric Pharmaceuticals, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Oric Pharmaceuticals, Inc. (ORIC)DirectorSale6,700$12.91$86,524
Jul 24, 2026Oric Pharmaceuticals, Inc. (ORIC)DirectorSale13,100$12.02$157,462
Jul 6, 2026Oric Pharmaceuticals, Inc. (ORIC)DirectorSale300$12.00$3,600